Drug intelligence / Profile preview

high molecular weight sodium hyaluronate

Development stage
Unknown
Lead developer
Anika Therapeutics
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intraarticular
01

Overview

**High molecular weight sodium hyaluronate** is the sodium salt form of hyaluronic acid, a long-chain glycosaminoglycan naturally present in human connective tissues. High molecular weight formulations, such as the one found in ORTHOVISC, possess a viscoelastic property permitting their use as intra-articular injections for supplementation of synovial fluid, leading to improved joint lubrication and shock absorption. The mechanism involves providing mechanical support and possibly modulating the inflammatory response in the joint. ORTHOVISC contains sodium hyaluronate extracted from rooster combs, with a molecular weight ranging from 1 to 2.9 million daltons, delivered as a 15 mg/mL solution for injection[1]. Its primary indication is pain management in osteoarthritis of the knee in patients unresponsive to conservative therapies[1][2][5].

Brand names
ORTHOVISC
Other names
high molecular weight sodium hyaluronansodium hyaluronate (high molecular weight)
02

Targets

CD44 (CD44 antigen)ICAM1 (Intercellular Adhesion Molecule 1)RHAMM (Hyaluronan-mediated motility receptor)

Beyond the preview

Go deeper on high molecular weight sodium hyaluronate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on high molecular weight sodium hyaluronate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call